Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies
Gonzalo P. Solis, … , Mikhail Savitsky, Vladimir L. Katanaev
Gonzalo P. Solis, … , Mikhail Savitsky, Vladimir L. Katanaev
Published June 14, 2024
Citation Information: J Clin Invest. 2024;134(15):e172057. https://doi.org/10.1172/JCI172057.
View: Text | PDF
Research Article Cell biology Genetics Article has an altmetric score of 6

Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies

  • Text
  • PDF
Abstract

GNAO1 mutated in pediatric encephalopathies encodes the major neuronal G protein Gαo. Of the more than 80 pathogenic mutations, most are single amino acid substitutions spreading across the Gαo sequence. We performed extensive characterization of Gαo mutants, showing abnormal GTP uptake and hydrolysis and deficiencies in binding Gβγ and RGS19. Plasma membrane localization of Gαo was decreased for a subset of mutations that leads to epilepsy; dominant interactions with GPCRs also emerged for the more severe mutants. Pathogenic mutants massively gained interaction with Ric8A and, surprisingly, Ric8B proteins, relocalizing them from cytoplasm to Golgi. Of these 2 mandatory Gα-subunit chaperones, Ric8A is normally responsible for the Gαi/Gαo, Gαq, and Gα12/Gα13 subfamilies, and Ric8B solely responsible for Gαs/Gαolf. Ric8 mediates the disease dominance when engaging in neomorphic interactions with pathogenic Gαo through imbalance of the neuronal G protein signaling networks. As the strength of Gαo-Ric8B interactions correlates with disease severity, our study further identifies an efficient biomarker and predictor for clinical manifestations in GNAO1 encephalopathies. Our work uncovers the neomorphic molecular mechanism of mutations underlying pediatric encephalopathies and offers insights into other maladies caused by G protein malfunctioning and further genetic diseases.

Authors

Gonzalo P. Solis, Alexey Koval, Jana Valnohova, Arghavan Kazemzadeh, Mikhail Savitsky, Vladimir L. Katanaev

×

Figure 5

GNAO1 mutants acquire a neomorphic interaction with Ric8A.

Options: View larger image (or click on image) Download as PowerPoint

GNAO1 mutants acquire a neomorphic interaction with Ric8A.
(A–C) N2a ce...
(A–C) N2a cells were cotransfected with GFP-Ric8A and nontagged wild-type Gαo, encephalopathy mutants, and the GTPase-dead Q205L mutant as control. The immunoprecipitation (IP) of GFP-Ric8A was achieved with a nanobody against GFP and the interaction with Gαo variants was determined by Western blot (WB), using antibodies against GFP and against Gαo: clone E1 (A and B) or A2 (C). (D) Quantification of the co-IP of Gαo variants by Ric8A (n = 3–4). Data are color-coded according to their involvement in developmental and epileptic encephalopathy-17 (DEE17; red) or neurodevelopmental disorder with involuntary movements (NEDIM; blue). (E) The level of the Gαo-Ric8A interaction pooled according to DEE17 or NEDIM. (F) A scatterplot showing a nonsignificant negative correlation between disease onset and Ric8A interaction of Gαo mutants. Note the log scale in the y axis. (G) N2a cells coexpressing GFP-Ric8A and nontagged wild-type Gαo or selected encephalopathy mutants were immunostained against Gαo and stained with DAPI in blue for nuclei. (H) Quantification of the mean fluorescence intensity ratio of GFP-Ric8A at the Golgi versus total cell (n = 57–60). Scale bar: 10 μm. Data represent mean ± SEM. Data in D and H were analyzed by 1-way ANOVA followed by Dunnett’s multiple-comparison test, in E by 2-tailed Mann-Whitney test, and in F by 2-tailed Spearman’s correlation test; rank correlation coefficient (rs) and P value are indicated. NS, not significant. *P < 0.05; ***P < 0.001; ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
On 1 Facebook pages
4 readers on Mendeley
See more details